Latest Private COVID-19 Suit Targets Sorrento Therapeutics, Overall Case Total Grows [Sponsored]


The complaint alleges that Sorrento Therapeutics violated federal securities laws by making false claims about its development of an antibody product for COVID-19.

Source link